Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30 June, 2024, scheduled on Monday, 12th August, 2024 at 03:30 P.M. IST.07-08-2024